A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes

The novel highly transmissible human coronavirus SARS-CoV-2 is the causative agent of the COVID-19 pandemic. Thus far, there is no approved therapeutic drug specifically targeting this emerging virus. Here we report the isolation and characterization of a panel of human neutralizing monoclonal antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Noy-Porat, Tal, Makdasi, Efi, Alcalay, Ron, Mechaly, Adva, Levy, Yinon, Bercovich-Kinori, Adi, Zauberman, Ayelet, Tamir, Hadas, Yahalom-Ronen, Yfat, Israeli, Ma’ayan, Epstein, Eyal, Achdout, Hagit, Melamed, Sharon, Chitlaru, Theodor, Weiss, Shay, Peretz, Eldar, Rosen, Osnat, Paran, Nir, Yitzhaki, Shmuel, Shapira, Shmuel C., Israely, Tomer, Mazor, Ohad, Rosenfeld, Ronit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452893/
https://www.ncbi.nlm.nih.gov/pubmed/32855401
http://dx.doi.org/10.1038/s41467-020-18159-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452893/
https://www.ncbi.nlm.nih.gov/pubmed/32855401
http://dx.doi.org/10.1038/s41467-020-18159-4

Ejemplares similares